July 16, 2025 · Form 4 insider transaction
Salkind Gene bought 150,000 shares of UPXI at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4.
Vests quarterly in equal installments over 12 months beginning July 1, 2025.; The shares of Common Stock reported herein were granted pursuant to the Issuer's Equity Incentive Plan.